696
Views
10
CrossRef citations to date
0
Altmetric
Review Articles

The opportunistic nature of gut commensal microbiota

&
Pages 739-763 | Received 16 Feb 2022, Accepted 05 Oct 2022, Published online: 18 Oct 2022

References

  • Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. 2001. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol. 167(3):1609–1616.
  • Abt MC, Artis D. 2013. The dynamic influence of commensal bacteria on the immune response to pathogens. Curr Opin Microbiol. 16(1):4–9.
  • Ailloud F, Didelot X, Woltemate S, Pfaffinger G, Overmann J, Bader RC, Schulz C, Malfertheiner P, Suerbaum S. 2019. Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps. Nat Commun. 10(1):1–13.
  • Anhê FF, Barra NG, Cavallari JF, Henriksbo BD, Schertzer JD. 2021. Metabolic endotoxemia is dictated by the type of lipopolysaccharide. Cell Rep. 36(11):109691.
  • Assimakopoulos SF, Triantos C, Maroulis I, Gogos C. 2018. The role of the gut barrier function in health and disease. Gastroenterology Res. 11(4):261–263.
  • Barr JJ, Auro R, Furlan M, Whiteson KL, Erb ML, Pogliano J, Stotland A, Wolkowicz R, Cutting AS, Doran KS, et al. 2013. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc Natl Acad Sci U S A. 110(26):10771–10776.
  • Barraud D, Bollaert P-E, Gibot S. 2013. Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials. Chest. 143(3):646–655.
  • Becattini S, Littmann ER, Carter RA, Kim SG, Morjaria SM, Ling L, Gyaltshen Y, Fontana E, Taur Y, Leiner IM, et al. 2017. Commensal microbes provide first line defense against Listeria monocytogenes infection. J Exp Med. 214(7):1973–1989.
  • Belkaid Y, Hand TW. 2014. Role of the microbiota in immunity and inflammation. Cell. 157(1):121–141.
  • Bhar S, Bose T, Mande SS. 2020. Can pathogenic and nonpathogenic bacteria be distinguished by sensory protein abundance? Appl Environ Microbiol. 86(14):e00478–20.
  • Bischoff SC. 2011. ‘Gut health’: a new objective in medicine? BMC Med. 9(1):1–14.
  • Boldock E, Surewaard BGJ, Shamarina D, Na M, Fei Y, Ali A, Williams A, Pollitt EJG, Szkuta P, Morris P, et al. 2018. Human skin commensals augment Staphylococcus aureus pathogenesis. Nat Microbiol. 3(8):881–890.
  • Brevi A, Cogrossi LL, Grazia G, Masciovecchio D, Impellizzieri D, Lacanfora L, Grioni M, Bellone M. 2020. Much more than IL-17A: cytokines of the IL-17 family between microbiota and cancer. Front Immunol. 11:565470.
  • Brown RL, Larkinson ML, Clarke TB. 2021. Immunological design of commensal communities to treat intestinal infection and inflammation. PLoS Pathog. 17(1):e1009191.
  • Brugger SD, Bomar L, Lemon KP. 2016. Commensal-pathogen interactions along the human nasal passages. PLoS Pathog. 12(7):e1005633.
  • Butta H, Sardana R, Vaishya R, Singh KN, Mendiratta L. 2017. Bifidobacterium: an emerging clinically significant metronidazole-resistant anaerobe of mixed pyogenic infections. Cureus. 9(4):e1134.
  • Cai R, Cheng C, Chen J, Xu X, Ding C, Gu B. 2020. Interactions of commensal and pathogenic microorganisms with the mucus layer in the colon. Gut Microbes. 11(4):680–690.
  • Casadevall A, Pirofski LA. 1999. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun. 67(8):3703–3713.
  • Casadevall A, Pirofski LA. 2000. Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease. Infect Immun. 68(12):6511–6518.
  • Casadevall A, Pirofski L-A. 2014. Microbiology: ditch the term pathogen. Nature News. 516(7530):165–166.
  • Cash HL, Whitham CV, Behrendt CL, Hooper LV. 2006. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 313(5790):1126–1130.
  • Chang PV, Hao L, Offermanns S, Medzhitov R. 2014. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 111(6):2247–2252.
  • Chassaing B, Ley RE, Gewirtz AT. 2014. Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology. 147(6):1363–1377.e17.
  • Cirrincione S, Neumann B, Zühlke D, Riedel K, Pessione E. 2019. Detailed soluble proteome analyses of a dairy-isolated Enterococcus faecalis: a possible approach to assess food safety and potential probiotic value. Front Nutr. 6:71.
  • Conway T, Cohen PS. 2015. Commensal and pathogenic Escherichia coli metabolism in the gut. Microbiol Spectr. 3(3):3–24.
  • Cornuault JK, Moncaut E, Loux V, Mathieu A, Sokol H, Petit M-A, De Paepe M. 2020. The enemy from within: a prophage of Roseburia intestinalis systematically turns lytic in the mouse gut, driving bacterial adaptation by CRISPR spacer acquisition. Isme J. 14(3):771–787.
  • Corrêa RO, Vieira A, Sernaglia EM, Lancellotti M, Vieira AT, Avila-Campos MJ, Rodrigues HG, Vinolo MAR. 2017. Bacterial short‐chain fatty acid metabolites modulate the inflammatory response against infectious bacteria. Cell Microbiol. 19(7):e12720.
  • Costa RL, Moreira J, Lorenzo A, Lamas CC. 2018. Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series. BMC Complement Altern Med. 18(1):1–8.
  • Cross SA, Callaway CW. 1984. D-Lactic acidosis and selected cerebellar ataxias. Mayo Clin Proc. 59(3):202–205.
  • Crossman LC, Chaudhuri RR, Beatson SA, Wells TJ, Desvaux M, Cunningham AF, Petty NK, Mahon V, Brinkley C, Hobman JL, et al. 2010. A commensal gone bad: complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407. J Bacteriol. 192(21):5822–5831.
  • Datta P, Gupta V, Mohi GK, Chander J, Janmeja AK. 2017. Lactobacillus coryniformis causing pulmonary infection in a patient with metastatic small cell carcinoma: case report and review of literature on lactobacillus pleuro-pulmonary infections. J Clin Diagn Res. 11(2):DE01–DE05.
  • David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 505(7484):559–563.
  • de Jong MF, Alto NM. 2018. Cooperative immune suppression by Escherichia coli and shigella effector proteins. Infect Immun. 86(4):e00560-17.
  • Denamur E, Matic I. 2006. Evolution of mutation rates in bacteria. Mol Microbiol. 60(4):820–827.
  • Dey P, Chaudhuri SR, Efferth T, Pal S. 2021. The intestinal 3M (microbiota, metabolism, metabolome) Zeitgeist–from fundamentals to future challenges. Free Radic Biol Med. 176:265–285.
  • Dey P, Ray Chaudhuri S. 2022. Cancer-associated microbiota: from mechanisms of disease causation to microbiota-centric anti-cancer approaches. Biology. 11(5):757.
  • Dey P, Sasaki GY, Wei P, Li J, Wang L, Zhu J, McTigue D, Yu Z, Bruno RS. 2019. Green tea extract prevents obesity in male mice by alleviating gut dysbiosis in association with improved intestinal barrier function that limits endotoxin translocation and adipose inflammation. J Nutr Biochem. 67:78–89.
  • Dey P. 2019. Gut microbiota in phytopharmacology: a comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions. Pharmacol Res. 147:104367.
  • Dey P. 2020a. Targeting gut barrier dysfunction with phytotherapies: effective strategy against chronic diseases. Pharmacol Res. 161(11):105135.
  • Dey P. 2020b. The role of gut microbiome in chemical-induced metabolic and toxicological murine disease models. Life Sci. 258:118172.
  • Diard M, Hardt W-D. 2017. Evolution of bacterial virulence. FEMS Microbiol Rev. 41(5):679–697.
  • Dingemanse C, Belzer C, van Hijum SA, Günthel M, Salvatori D, Dunnen JTd, Kuijper EJ, Devilee P, de Vos WM, van Ommen GB, et al. 2015. Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. CARCIN. 36(11):1388–1396.
  • Duarte SMB, Stefano JT, Miele L, Ponziani FR, Souza-Basqueira M, Okada LSRR, de Barros Costa FG, Toda K, Mazo DFC, Sabino EC, et al. 2018. Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: a prospective pilot study. Nutr Metab Cardiovasc Dis. 28(4):369–384.
  • Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI, Eilers E, Bader V, Haase S, Kaisler J, David C, et al. 2020. Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell. 180(6):1067–1080. e16.
  • Egervärn M, Lindmark H, Olsson J, Roos S. 2010. Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans. Antonie Van Leeuwenhoek. 97(2):189–200.
  • Elomaa E, Aho K. 1990. The colon, the rumen, and D-lactic acidosis. Lancet. 336:599–600.
  • Fast D, Kostiuk B, Foley E, Pukatzki S. 2018. Commensal pathogen competition impacts host viability. Proc Natl Acad Sci U S A. 115(27):7099–7104.
  • FDA. Fecal microbiota for transplantation: safety alert - risk of serious adverse events likely due to transmission of pathogenic organisms. 2020. https://www.fda.gov/safety/medical-product-safety-information/fecal-microbiota-transplantation-safety-alert-risk-serious-adverse-events-likely-due-transmission
  • Franz CM, Holzapfel WH, Stiles ME. 1999. Enterococci at the crossroads of food safety? Int J Food Microbiol. 47(1–2):1–24.
  • Franz CM, Muscholl-Silberhorn AB, Yousif NM, Vancanneyt M, Swings J, Holzapfel WH. 2001. Incidence of virulence factors and antibiotic resistance among Enterococci isolated from food. Appl Environ Microbiol. 67(9):4385–4389.
  • Freter R. 1992. Factors affecting the microecology of the gut. In: Probiotics. Dordrecht: Springer; p. 111–144.
  • Fritts RK, McCully AL, McKinlay JB. 2021. Extracellular metabolism sets the table for microbial cross-feeding. Microbiol Mol Biol Rev. 85(1):e00135–20.
  • Fuchs TM, Eisenreich W, Heesemann J, Goebel W. 2012. Metabolic adaptation of human pathogenic and related nonpathogenic bacteria to extra-and intracellular habitats. FEMS Microbiol Rev. 36(2):435–462.
  • Furuya-Kanamori L, Marquess J, Yakob L, Riley TV, Paterson DL, Foster NF, Huber CA, Clements ACA. 2015. Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect Dis. 15:516.
  • Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M, Brandi G, et al. 2009. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 31(4):677–689.
  • Gewirtz AT, Simon PO, Schmitt CK, Taylor LJ, Hagedorn CH, O'Brien AD, Neish AS, Madara JL. 2001. Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest. 107(1):99–109.
  • Ghosh AR. 2013. Appraisal of microbial evolution to commensalism and pathogenicity in humans. Clin Med Insights Gastroenterol. 6:1–12.
  • Giannakis M, Chen SL, Karam SM, Engstrand L, Gordon JI. 2008. Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci U S A. 105(11):4358–4363.
  • Gibson JF, Pidwill GR, Carnell OT, Surewaard BGJ, Shamarina D, Sutton JAF, Jeffery C, Derré-Bobillot A, Archambaud C, Siggins MK, et al. 2021. Commensal bacteria augment Staphylococcus aureus infection by inactivation of phagocyte-derived reactive oxygen species. PLoS Pathog. 17(9):e1009880.
  • Graver MA, Wade JJ. 2011. The role of acidification in the inhibition of Neisseria gonorrhoeae by vaginal lactobacilli during anaerobic growth. Ann Clin Microbiol Antimicrob. 10:8.
  • Gray MJ, Escalante-Semerena JC. 2010. A new pathway for the synthesis of α‐ribazole‐phosphate in Listeria innocua. Mol Microbiol. 77(6):1429–1438.
  • Gren C, Spiegelhauer MR, Rotbain EC, Ehmsen BK, Kampmann P, Andersen LP. 2019. Ruminococcus gnavus bacteraemia in a patient with multiple haematological malignancies. Access Microbiol. 1(8):e000048.
  • Gronbach K, Eberle U, Müller M, Ölschläger TA, Dobrindt U, Leithäuser F, Niess JH, Döring G, Reimann J, Autenrieth IB, et al. 2010. Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host. Infect Immun. 78(7):3036–3046.
  • Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, Shulzhenko N. 2020. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 51:102590.
  • Gustafsson I, Sjölund M, Torell E, Johannesson M, Engstrand L, Cars O, Andersson DI. 2003. Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage. J Antimicrob Chemother. 52(4):645–650.
  • Hadjisymeou S, Loizou P, Kothari P. 2013. Lactococcus lactis cremoris infection: not rare anymore? BMJ Case Rep. 2013(may09 1):bcr2012008479.
  • Han YW. 2015. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol. 23:141–147.
  • Hanchi H, Mottawea W, Sebei K, Hammami R. 2018. The genus Enterococcus: between probiotic potential and safety concerns—an update. Front Microbiol. 9:1791.
  • Hansen SGK, Skov MN, Justesen US. 2013. Two cases of Ruminococcus gnavus bacteremia associated with diverticulitis. J Clin Microbiol. 51(4):1334–1336.
  • Hassall J, Cheng JK, Unnikrishnan M. 2021. Dissecting individual interactions between pathogenic and commensal bacteria within a multispecies gut microbial community. Msphere. 6(2):e00013–21.
  • Heeney DD, Gareau MG, Marco ML. 2018. Intestinal Lactobacillus in health and disease, a driver or just along for the ride? Curr Opin Biotechnol. 49:140–147.
  • Henriques SF, Dhakan DB, Serra L, Francisco AP, Carvalho-Santos Z, Baltazar C, Elias AP, Anjos M, Zhang T, Maddocks ODK, et al. 2020. Metabolic cross-feeding in imbalanced diets allows gut microbes to improve reproduction and alter host behaviour. Nat Commun. 11(1):1–15.
  • Honda K, Moto M, Uchida N, He F, Hashizume N. 2012. Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice. J Clin Biochem Nutr. 51(2):96–101.
  • Honeycutt TC, El Khashab M, Wardrop RM, III, McNeal-Trice K, Honeycutt AL, Christy CG, et al. 2007. Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatric Crit Care Med. 8(5):452–458.
  • Howe C, Kim SJ, Mitchell J, Im E, Kim YS, Kim YS, Rhee SH. 2018. Differential expression of tumor-associated genes and altered gut microbiome with decreased Akkermansia muciniphila confer a tumor-preventive microenvironment in intestinal epithelial Pten-deficient mice. Biochim Biophys Acta Mol Basis Dis. 1864(12):3746–3758.
  • Huang P-Y, Yang Y-C, Wang C-I, Hsiao P-W, Chiang H-I, Chen T-W. 2021. Increase in akkermansiaceae in gut microbiota of prostate cancer-bearing mice. IJMS. 22(17):9626.
  • Hummel A, Holzapfel WH, Franz CM. 2007. Characterisation and transfer of antibiotic resistance genes from enterococci isolated from food. Syst Appl Microbiol. 30(1):1–7.
  • Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 139(3):485–498.
  • Jacobsen L, Wilcks A, Hammer K, Huys G, Gevers D, Andersen SR. 2007. Horizontal transfer of tet (M) and erm (B) resistance plasmids from food strains of Lactobacillus plantarum to Enterococcus faecalis JH2-2 in the gastrointestinal tract of gnotobiotic rats. FEMS Microbiol Ecol. 59(1):158–166.
  • Jellbauer S, Perez Lopez A, Behnsen J, Gao N, Nguyen T, Murphy C, Edwards RA, Raffatellu M. 2016. Beneficial effects of sodium phenylbutyrate administration during infection with Salmonella enterica serovar typhimurium. Infect Immun. 84(9):2639–2652.
  • Jiang F, Meng D, Weng M, Zhu W, Wu W, Kasper D, Walker WA. 2017. The symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis inhibits IL-1β-induced inflammation in human fetal enterocytes via toll receptors 2 and 4. PLoS One. 12(3):e0172738.
  • Jiminez JA, Uwiera TC, Abbott DW, Uwiera RRE, Inglis GD. 2017. Butyrate supplementation at high concentrations alters enteric bacterial communities and reduces intestinal inflammation in mice infected with Citrobacter rodentium. mSphere. 2(4):e00243-17.
  • Jochum L, Stecher B. 2020. Label or concept–what is a pathobiont? Trends Microbiol. 28(10):789–792.
  • Johnson JL, Jones MB, Cobb BA. 2015. Polysaccharide A from the capsule of Bacteroides fragilis induces clonal CD4+ T cell expansion. J Biol Chem. 290(8):5007–5014.
  • Johnson TJ, Nolan LK. 2009. Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol Mol Biol Rev. 73(4):750–774.
  • Kamada N, Kim Y-G, Sham HP, Vallance BA, Puente JL, Martens EC, Núñez G. 2012. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science. 336(6086):1325–1329.
  • Khalesi S, Bellissimo N, Vandelanotte C, Williams S, Stanley D, Irwin C. 2019. A review of probiotic supplementation in healthy adults: helpful or hype? Eur J Clin Nutr. 73(1):24–37.
  • Kim YJ, Kang HY, Han Y, Lee MS, Lee HJ. 2017. A bloodstream infection by Ruminococcus gnavus in a patient with a gall bladder perforation. Anaerobe. 47:129–131.
  • Köhler C-D, Dobrindt U. 2011. What defines extraintestinal pathogenic Escherichia coli? Int J Med Microbiol. 301(8):642–647.
  • Koli P, Sudan S, Fitzgerald D, Adhya S, Kar S. 2011. Conversion of commensal Escherichia coli K-12 to an invasive form via expression of a mutant histone-like protein. mBio. 2(6):e00182–11.
  • Kothari D, Patel S, Kim S-K. 2019. Probiotic supplements might not be universally-effective and safe: a review. Biomed Pharmacother. 111:537–547.
  • Kowlgi NG, Chhabra L. 2015. D-lactic acidosis: an underrecognized complication of short bowel syndrome. Gastroenterol Res Pract. 2015:476215.
  • Kumar P, Monin L, Castillo P, Elsegeiny W, Horne W, Eddens T, Vikram A, Good M, Schoenborn AA, Bibby K, et al. 2016. Intestinal interleukin-17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation. Immunity. 44(3):659–671.
  • LeClerc JE, Li B, Payne WL, Cebula TA. 1996. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science. 274(5290):1208–1211.
  • Lertpiriyapong K, Whary MT, Muthupalani S, Lofgren JL, Gamazon ER, Feng Y, Ge Z, Wang TC, Fox JG. 2014. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut. 63(1):54–63.
  • Li X-Q, Zhu Y-H, Zhang H-F, Yue Y, Cai Z-X, Lu Q-P, Zhang L, Weng XG, Zhang FJ, Zhou D, et al. 2012. Risks associated with high-dose Lactobacillus rhamnosus in an Escherichia coli model of piglet diarrhoea: intestinal microbiota and immune imbalances. PLoS One. 7:e40666.
  • Li Z-P, Liu J-X, Lu L-L, Wang L-L, Xu L, Guo Z-H, Dong Q-J. 2021. Overgrowth of Lactobacillus in gastric cancer. World J Gastrointest Oncol. 13(9):1099–1108.
  • Lood R, Waldetoft KW, Nordenfelt P. 2015. Localization-triggered bacterial pathogenesis. Future Microbiol. 10(10):1659–1668.
  • Madan R, Kolter R, Mahadevan S. 2005. Mutations that activate the silent bgl operon of Escherichia coli confer a growth advantage in stationary phase. J Bacteriol. 187(23):7912–7917.
  • Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R. 2020. The firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients. 12(5):1474.
  • Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, Wollam A, Shah N, Wang C, Magrini V, Wilson RK, et al. 2009. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci USA. 106(14):5859–5864.
  • Malek A, De la Hoz A, Gomez-Villegas SI, Nowbakht C, Arias CA. 2019. Lactococcus garvieae, an unusual pathogen in infective endocarditis: case report and review of the literature. BMC Infect Dis. 19(1):1–10.
  • Maltby R, Leatham-Jensen MP, Gibson T, Cohen PS, Conway T. 2013. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157: H7 in the mouse intestine. PLoS One. 8(1):e53957.
  • Martens EC, Neumann M, Desai MS. 2018. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat Rev Microbiol. 16(8):457–470.
  • Maurelli AT, Fernández RE, Bloch CA, Rode CK, Fasano A. 1998. “Black holes” and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc Natl Acad Sci U S A. 95(7):3943–3948.
  • Mazmanian SK, Round JL, Kasper DL. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 453(7195):620–625.
  • McLaren MR, Callahan BJ. 2020. Pathogen resistance may be the principal evolutionary advantage provided by the microbiome. Philos Trans R Soc Lond B Biol Sci. 375(1808):20190592.
  • Metcalf CJE, Koskella B. 2019. Protective microbiomes can limit the evolution of host pathogen defense. Evol Lett. 3(5):534–543.
  • Million M, Lagier J-C, Yahav D, Paul M. 2013. Gut bacterial microbiota and obesity. Clin Microbiol Infect. 19(4):305–313.
  • Morris BE, Henneberger R, Huber H, Moissl-Eichinger C. 2013. Microbial syntrophy: interaction for the common good. FEMS Microbiol Rev. 37(3):384–406.
  • Mosca A, Leclerc M, Hugot JP. 2016. Gut microbiota diversity and human diseases: should we reintroduce key predators in our ecosystem? Front Microbiol. 7:455.
  • Moxon ER, Murphy PA. 1978. Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism. Proc Natl Acad Sci USA. 75(3):1534–1536.
  • Murray G, Balmer AJ, Herbert J, Hadijirn NF, Kemp CL, Matuszewska M, Bruchmann S, Hossain ASMM, Gottschalk M, Tucker AW et al. 2021. Mutation rate dynamics reflect ecological change in an emerging zoonotic pathogen. PLoS Genet. 17:e1009864.
  • Najdenski H, Iteman I, Carniel E. 1995. The genome of Yersinia enterocolitica is the most stable of the three pathogenic species. Contrib Microbiol Immunol. 13:281–284.
  • Nascimento LCS, Casarotti SN, Todorov SD, Penna ALB. 2019. Probiotic potential and safety of enterococci strains. Ann Microbiol. 69(3):241–252.
  • Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL. 2000. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science. 289(5484):1560–1563.
  • Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S, Naidu N, Choudhury B, Weimer BC, Monack DM, et al. 2013. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature. 502(7469):96–99.
  • Nguyen M-T, Uebele J, Kumari N, Nakayama H, Peter L, Ticha O, Woischnig A-K, Schmaler M, Khanna N, Dohmae N, et al. 2017. Lipid moieties on lipoproteins of commensal and non-commensal staphylococci induce differential immune responses. Nat Commun. 8(1):1–12.
  • Noh CK, Lee KJ. 2020. Fecal microbiota alterations and small intestinal bacterial overgrowth in functional abdominal bloating/distention. J Neurogastroenterol Motil. 26(4):539–549.
  • Okubo H, Sakoda H, Kushiyama A, Fujishiro M, Nakatsu Y, Fukushima T, Matsunaga Y, Kamata H, Asahara T, Yoshida Y, et al. 2013. Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model. Am J Physiol Gastrointest Liver Physiol. 305(12):G911–G918.
  • Ortega-Cava CF, Ishihara S, Rumi MAK, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y, Kinoshita Y. 2003. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol. 170(8):3977–3985.
  • Ottman N, Reunanen J, Meijerink M, Pietilä TE, Kainulainen V, Klievink J, Huuskonen L, Aalvink S, Skurnik M, Boeren S, et al. 2017. Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS One. 12(3):e0173004–e.
  • Paczosa MK, Mecsas J. 2016. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 80(3):629–661.
  • Park D-Y, Ahn Y-T, Park S-H, Huh C-S, Yoo S-R, Yu R, Sung M-K, McGregor RA, Choi M-S. 2013. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One. 8(3):e59470.
  • Pathak P, Trilligan C, Rapose A. 2014. Bifidobacterium–friend or foe? A case of urinary tract infection with Bifidobacterium species. BMJ Case Rep. 2014(sep24 1):bcr2014205122.
  • Pearson T, Sahl JW, Hepp CM, Handady K, Hornstra H, Vazquez AJ, Settles E, Mayo M, Kaestli M, Williamson CHD, et al. 2020. Pathogen to commensal? Longitudinal within-host population dynamics, evolution, and adaptation during a chronic > 16-year Burkholderia pseudomallei infection. PLoS Pathog. 16(3):e1008298.
  • Pessione E. 2020. The Russian doll model: how bacteria shape successful and sustainable inter-kingdom relationships. Front Microbiol. 11:573759.
  • Peterson DA, McNulty NP, Guruge JL, Gordon JI. 2007. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe. 2(5):328–339.
  • Png CW, Lindén SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI, McGuckin MA, Florin THJ. 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 105(11):2420–2428.
  • Postler TS, Ghosh S. 2017. Understanding the holobiont: how microbial metabolites affect human health and shape the immune system. Cell Metab. 26(1):110–130.
  • Pray L. 2008. Antibiotic resistance, mutation rates and MRSA. Nat Educ. 1(1):30.
  • Proença JT, Barral DC, Gordo I. 2017. Commensal-to-pathogen transition: One-single transposon insertion results in two pathoadaptive traits in Escherichia coli-macrophage interaction. Sci Rep. 7(1):1–12.
  • Qiang X, Liotta AS, Shiloach J, Gutierrez JC, Wang H, Ochani M, Ochani K, Yang H, Rabin A, LeRoith D, et al. 2017. New melanocortin-like peptide of E. coli can suppress inflammation via the mammalian melanocortin-1 receptor (MC1R): possible endocrine-like function for microbes of the gut. NPJ Biofilms Microbiomes. 3:31.
  • Quigley EMM, Murray JA, Pimentel M. 2020. AGA clinical practice update on small intestinal bacterial overgrowth: expert review. Gastroenterology. 159(4):1526–1532.
  • Ramakrishnan SK, Zhang H, Ma X, Jung I, Schwartz AJ, Triner D, Devenport SN, Das NK, Xue X, Zeng MY, et al. 2019. Intestinal non-canonical NFκB signaling shapes the local and systemic immune response. Nat Commun. 10(1):660.
  • Rath S, Rud T, Karch A, Pieper DH, Vital M. 2018. Pathogenic functions of host microbiota. Microbiome. 6(1):1–13.
  • Revitt-Mills SA, Robinson A. 2020. Antibiotic-induced mutagenesis: under the microscope. Front Microbiol. 11:585175.
  • Rezaïki L, Lamberet G, Derré A, Gruss A, Gaudu P. 2008. Lactococcus lactis produces short‐chain quinones that cross‐feed Group B Streptococcus to activate respiration growth. Mol Microbiol. 67(5):947–957.
  • Ribet D, Cossart P. 2015. How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes Infect. 17(3):173–183.
  • Rocca MF, Aguerre L, Cipolla L, Martínez C, Armitano R, Dangiolo G, Prieto M. 2018. Lactobacillus spp. invasive infections in Argentina. Int J Infect Dis. 73:163.
  • Rolhion N, Chassaing B, Nahori M-A, de Bodt J, Moura A, Lecuit M, Dussurget O, Bérard M, Marzorati M, Fehlner-Peach H, et al. 2019. A Listeria monocytogenes bacteriocin can target the commensal Prevotella copri and modulate intestinal infection. Cell Host Microbe. 26(5):691–701. e5.
  • Rooks MG, Garrett WS. 2016. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 16(6):341–352.
  • Rosenberg E, Zilber-Rosenberg I. 2018. The hologenome concept of evolution after 10 years. Microbiome. 6(1):1–14.
  • Rossi F, Amadoro C, Colavita G. 2019. Members of the Lactobacillus Genus Complex (LGC) as opportunistic pathogens: a review. Microorganisms. 7(5):126.
  • Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Järvinen A. 2004. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis. 38(1):62–69.
  • Sarker P, Ahmed S, Tiash S, Rekha RS, Stromberg R, Andersson J, Bergman P, Gudmundsson GH, Agerberth B, Raqib R, et al. 2011. Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy. PLoS One. 6(6):e20637.
  • Seth EC, Taga ME. 2014. Nutrient cross-feeding in the microbial world. Front Microbiol. 5:350.
  • Shah SC, Day LW, Somsouk M, Sewell JL. 2013. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 38(8):925–934.
  • Sharma V, Rodionov DA, Leyn SA, Tran D, Iablokov SN, Ding H, Peterson DA, Osterman AL, Peterson SN. 2019. B-vitamin sharing promotes stability of gut microbial communities. Front Microbiol. 10:1485.
  • Shekhar S, Schenck K, Petersen FC. 2017. Exploring host–commensal interactions in the respiratory tract. Front Immunol. 8:1971.
  • Sherid M, Samo S, Sulaiman S, Husein H, Sifuentes H, Sridhar S. 2016. Liver abscess and bacteremia caused by lactobacillus: role of probiotics? Case report and review of the literature. BMC Gastroenterol. 16(1):1–6.
  • Shin CM, Kim N, Kim YS, Nam RH, Park JH, Lee DH, Seok Y-J, Kim Y-R, Kim J-H, Kim JM, et al. 2016. Impact of long-term proton pump inhibitor therapy on gut microbiota in F344 rats: pilot study. Gut Liver. 10(6):896–901.
  • Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, et al. 2014. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 40(1):128–139.
  • Skov Sørensen UB, Yao K, Yang Y, Tettelin H, Kilian M. 2016. Capsular polysaccharide expression in commensal Streptococcus species: genetic and antigenic similarities to Streptococcus pneumoniae. mBio. 7(6):e01844–16.
  • Smith NW, Shorten PR, Altermann E, Roy NC, McNabb WC. 2019. The classification and evolution of bacterial cross-feeding. Front Ecol Evol. 7:153.
  • Sokurenko EV, Hasty DL, Dykhuizen DE. 1999. Pathoadaptive mutations: gene loss and variation in bacterial pathogens. Trends Microbiol. 7(5):191–195.
  • Srinivasan N. 2010. Telling apart friend from foe: discriminating between commensals and pathogens at mucosal sites. Innate Immun. 16(6):391–404.
  • Stacy A, Fleming D, Lamont RJ, Rumbaugh KP, Whiteley M. 2016. A commensal bacterium promotes virulence of an opportunistic pathogen via cross-respiration. mBio. 7(3):e00782–16.
  • Steimle A, Autenrieth IB, Frick J-S. 2016. Structure and function: lipid A modifications in commensals and pathogens. Int J Med Microbiol. 306(5):290–301.
  • Stella GJ. 1980. Peptococcla urinary tract infection with bacteremia: a case report. J Urol. 124(1):158–159.
  • Suez J, Zmora N, Zilberman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, Zur M, Regev-Lehavi D, Ben-Zeev Brik R, Federici S, et al. 2018. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell. 174(6):1406–1423. e16.
  • Suresh A, Rajesh A, Bhat RM, Rai Y. 2009. Cytolytic vaginosis: a review. Indian J Sex Transm Dis AIDS. 30(1):48–50.
  • Sydenham TV, Arpi M, Klein K, Justesen US. 2014. Four cases of bacteremia caused by Oscillibacter ruminantium, a newly described species. J Clin Microbiol. 52(4):1304–1307.
  • Szajewska H. 2016. What are the indications for using probiotics in children? Arch Dis Child. 101(4):398–403.
  • Tanoue T, Umesaki Y, Honda K. 2010. Immune responses to gut microbiota-commensals and pathogens. Gut Microbes. 1(4):224–233.
  • Tropini C. 2021. How the physical environment shapes the microbiota. mSystems. 6(4):e00675.
  • Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, Fueda Y, Kotani J. 2008. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res. 28(5):321–328.
  • Vancamelbeke M, Vermeire S. 2017. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol. 11(9):821–834.
  • Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. 2011. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem. 22(9):849–855.
  • von Eiff C, Becker K, Machka K, Stammer H, Peters G. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 344(1):11–16.
  • Wang L, Tang L, Feng Y, Zhao S, Han M, Zhang C, Yuan G, Zhu J, Cao S, Wu Q, et al. 2020. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8(+) T cells in mice. Gut. 69(11):1988–1997.
  • Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, Yan F, Cao H, Wang B. 2016. Systematic review: adverse events of fecal microbiota transplantation. PLoS One. 11(8):e0161174.
  • Wang Z, Zhang X, Zhu L, Yang X, He F, Wang T, Bao T, Lu H, Wang H, Yang S, et al. 2020. Inulin alleviates inflammation of alcoholic liver disease via SCFAs-inducing suppression of M1 and facilitation of M2 macrophages in mice. Int Immunopharmacol. 78:106062.
  • Weber E, Reynaud Q, Suy F, Gagneux-Brunon A, Carricajo A, Guillot A, Botelho-Nevers E. 2015. Bifidobacterium species bacteremia: risk factors in adults and infants. Clin Infect Dis. 61(3):482–484.
  • Webster GF, Ruggieri MR, McGinley KJ. 1981. Correlation of Propionibacterium acnes populations with the presence of triglycerides on nonhuman skin. Appl Environ Microbiol. 41(5):1269–1270.
  • Wei W, Cao Z, Zhu Y-L, Wang X, Ding G, Xu H, Jia P, Qu D, Danchin A, Li Y. 2006. Conserved genes in a path from commensalism to pathogenicity: comparative phylogenetic profiles of Staphylococcus epidermidis RP62A and ATCC12228. BMC Genomics. 7(1):1–12.
  • Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. 2013. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 8(8):e70803.
  • Werner G, Coque TM, Franz CMAP, Grohmann E, Hegstad K, Jensen L, van Schaik W, Weaver K. 2013. Antibiotic resistant enterococci-tales of a drug resistance gene trafficker. Int J Med Microbiol. 303(6–7):360–379.
  • Wilks J, Beilinson H, Golovkina TV. 2013. Dual role of commensal bacteria in viral infections. Immunol Rev. 255(1):222–229.
  • Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, Keestra AM, Laughlin RC, Gomez G, Wu J, Lawhon SD, et al. 2013. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science. 339(6120):708–711.
  • World Health Organization. 2020. Global report on the epidemiology and burden of sepsis: Current evidence, identifying gaps and future directions. Geneva: WHO.
  • Wu KQ, Sun WJ, Li N, Chen YQ, Wei YL, Chen DF. 2019. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance. Scand J Gastroenterol. 54(12):1419–1425.
  • Wu Y, Wang Y, Yang H, Li Q, Gong X, Zhang G, Zhu K. 2021. Resident bacteria contribute to opportunistic infections of the respiratory tract. PLoS Pathog. 17(3):e1009436.
  • Wurtzel O, Sesto N, Mellin JR, Karunker I, Edelheit S, Bécavin C, Archambaud C, Cossart P, Sorek R. 2012. Comparative transcriptomics of pathogenic and non‐pathogenic Listeria species. Mol Syst Biol. 8(1):583.
  • Xavier JB, Young VB, Skufca J, Ginty F, Testerman T, Pearson AT, Macklin P, Mitchell A, Shmulevich I, Xie L, et al. 2020. The cancer microbiome: distinguishing direct and indirect effects requires a systemic view. Trends Cancer. 6(3):192–204.
  • Yang K, Niu J, Zuo T, Sun Y, Xu Z, Tang W, Liu Q, Zhang J, Ng EK, Wong SK, et al. 2021. Alterations in the gut virome in obesity and type 2 diabetes mellitus. Gastroenterology. 161(4):1257–1269.e13.
  • Young BC, Wu C-H, Gordon NC, Cole K, Price JR, Liu E, Sheppard AE, Perera S, Charlesworth J, Golubchik T, et al. 2017. Severe infections emerge from commensal bacteria by adaptive evolution. elife. 6:e30637.
  • Yu Z-T, Chen C, Kling DE, Liu B, McCoy JM, Merighi M, Heidtman M, Newburg DS. 2013. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology. 23(2):169–177.
  • Zaborin A, Penalver Bernabe B, Keskey R, Sangwan N, Hyoju S, Gottel N, Gilbert JA, Zaborina O, Alverdy JC. 2020. Spatial compartmentalization of the microbiome between the lumen and crypts is lost in the murine cecum following the process of surgery, including overnight fasting and exposure to antibiotics. mSystems. 5(3):e00377–20.
  • Załuga J, Stragier P, Baeyen S, Haegeman A, Van Vaerenbergh J, Maes M, De Vos P. 2014. Comparative genome analysis of pathogenic and non-pathogenic Clavibacter strains reveals adaptations to their lifestyle. BMC Genomics. 15(1):314–392.
  • Zhang H, Du M, Yang Q, Zhu MJ. 2016. Butyrate suppresses murine mast cell proliferation and cytokine production through inhibiting histone deacetylase. J Nutr Biochem. 27:299–306.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.